Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. .

Menu

Articles

Read articles and interviews on investing in startups, venture capital funds, tax saving and retirement planning strategies and the latest industry trends, from diversity to cleantech and sustainability. You''ll also find interviews and podcasts with our founders and angel investors.

Budget 2026: What CGT at Income Tax Rates Would Cost

Budget 2026: What CGT at Income Tax Rates Would Cost

CGT at 20%, 40% and 45%? We ran six real-world examples ahead of the 28 October Budget, from a £285,000 second-home gain to a £2m business sale.

Backing the next generation of Nottingham spin-outs: watch the University of Nottingham EIS Fund I webinar

Backing the next generation of Nottingham spin-outs: watch the University of Nottingham EIS Fund I webinar

Watch Nottingham Technology Ventures and two University of Nottingham spin-out founders explain how the University of Nottingham EIS Fund I backs the university's spin-outs. Capital at risk.

Jove: how a contractor marketplace led Amanda Cai to rebuild business insurance

Jove: how a contractor marketplace led Amanda Cai to rebuild business insurance

How Amanda Cai built Jove, why Angel Academe's angels, a super angel and Access EIS backed it before launch in 2021, the funding record since, and where the early investors stand.

Angel Academe EIS Fund 1: meet the eight portfolio companies

28 September 2026

Angel Academe EIS Fund 1: meet the eight portfolio companies

Meet the eight companies in Angel Academe EIS Fund 1, from menopause care to hospital infection control. Download the free portfolio guide.

Quantified Imaging: enabling precision medicine in brain disease with MRI

23 September 2026

Quantified Imaging: enabling precision medicine in brain disease with MRI

How a 2023 University of Nottingham spin-out turned 20 years of MRI research into FDA-cleared software for dementia care, and what comes next.

Sector only explains about a tenth of the all-female funding gap

21 September 2026

Sector only explains about a tenth of the all-female funding gap

Does sector choice explain the all-female funding gap? SyndicateRoom's analysis of 9,000 Companies House rounds finds it accounts for about a tenth.

Ki 13: how a hydrogen engineer's problem with arithmetic became a $5m seed round

17 September 2026

Ki 13: how a hydrogen engineer's problem with arithmetic became a $5m seed round

Carbon13 backed Ki Hydrogen (now Ki 13) in 2023 for £120,000. Every share price filed since, and where that holding stands now.

What to expect in the upcoming Budget

7 September 2026

What to expect in the upcoming Budget

On 28 October 2026, Chancellor John Healey delivers his first Budget. Here's what EIS and SEIS investors need to know before that date — and why acting sooner may matter.

£22.2bn: the record capital gains tax bill turning 2026 asset sales into startup portfolios

£22.2bn: the record capital gains tax bill turning 2026 asset sales into startup portfolios

HMRC collected a record £22.2bn in CGT in 2025/26. Here's how EIS deferral relief and SEIS reinvestment relief can help investors put that gain to work instead of handing it to the taxman.

Load more articles

Showing 9 of 117 articles

Risk warning: Please click here to read the full risk warning.

Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.

This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).

We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more. .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Syndicate Room Ltd is registered in England and Wales. Number 07697935. Registered office: Wellington House, East Road, Cambridge, Cambridgeshire, CB1 1BH, United Kingdom

General enquiries

Please note: our office hours are weekdays, 9.30am - 5.30pm.

Email:

contactus@syndicateroom.com

Phone:

Existing investors

Email:

investor.relations@syndicateroom.com

Phone: